The distribution of KIR-HLA functional blocks is different from North to South of Italy

Tissue Antigens

Volumn 83, Issue 3, 2014, Pages 168-173

  Fasano, M E ^a   Rendine, S ^a,b   Pasi, A ^c   Bontadini, A ^d   Cosentini, E ^e   Carcassi, C ^f   Capittini, C ^c   Cornacchini, G ^g   Espadas de Arias, A ^h   Garbarino, L ⁱ   Carella, G ^j   Mariotti, M L ^k   Mele, L ^l   Miotti, V ^m   Moscetti, A ⁿ   Nesci, S ^o   Ozzella, G ⁿ   Piancatelli, D ^p   Porfirio, B ^q   Riva, M R ^r   Romeo, G ^s   Tagliaferri, C ^t   Lombardo, C ^u   Testi, M ^v   Amoroso, A ^a,b   Martinetti, M ^c   more..

^a CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f UNIVERSITY OF CAGLIARI   (Italy)

^g OSPEDALE NIGUARDA CA GRANDA   (Italy)

^h FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

ⁱ GALLIERA HOSPITAL   (Italy)

^j Rheumatology and Clinical Immunology   (Italy)

^k CISANELLO HOSPITAL   (Italy)

^l C Arrigo Children's Hospital   (Italy)

^m SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

ⁿ SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^o AO Ospedali Riuniti Marche Nord   (Italy)

^p CNR   (Italy)

^q UNIVERSITY OF FLORENCE   (Italy)

^r SAN GERARDO HOSPITAL   (Italy)

^s BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^t SAN BORTOLO HOSPITAL   (Italy)

^u NATIONAL CANCER INSTITUTE   (Italy)

^v TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

more..

Author keywords

Co evolution; Environmental pressure; Genetic epistasis; Human leukocyte antigen ligands; Killer cell immunoglobulin like receptors

Indexed keywords

CO-EVOLUTION; ENVIRONMENTAL PRESSURE; GENETIC EPISTASIS; HUMAN LEUKOCYTE ANTIGEN LIGANDS; KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTORS;

ADULT; ALLELES; FEMALE; GENE FREQUENCY; GENETICS, POPULATION; GEOGRAPHY; HLA ANTIGENS; HUMANS; ITALY; LIGANDS; LINKAGE DISEQUILIBRIUM; MALE; RECEPTORS, KIR;

EID: 84894288298     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12299     Document Type: Article

References (27)

1. Moretta A, Bottino C, Vitale M et al. Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 1996: 14: 619-48.
2. Cella M, Longo A, Ferrara GB, Strominger JL, Colonna M. Nk3-specific natural killer cells are selectively inhibited by bw4-positive HLA alleles with isoleucine 80. J Exp Med 1994: 180: 1235-42.
3. Dohring C, Scheidegger D, Samaridis J, Cella M, Colonna M. A human killer inhibitory receptor specific for HLA-A1, 2. J Immunol 1996: 156: 3098-101.
4. Moretta L, Moretta A. Killer immunoglobulin-like receptors. Curr Opin Immunol 2004: 16: 626-33.
5. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005: 5: 201-14.
6. Hollenbach JA, Meenagh A, Sleator C et al. Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA. Tissue Antigens 2010: 76: 9-17.
7. Martin MP, Gao X, Lee JH et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002: 31: 429-34.
8. Parham P, Norman PJ, Abi-Rached L, Guethlein LA. Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules. Philos Trans R Soc Lond B Biol Sci 2012: 367: 800-11.
9. Du Z, Gjertson DW, Reed EF, Rajalingam R. Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans. Immunogenetics 2007: 59: 1-15.
10. Gendzekhadze K, Norman PJ, Abi-Rached L et al. Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands. Proc Natl Acad Sci U S A 2009: 106: 18692-7.
11. Guinan KJ, Cunningham RT, Meenagh A, Dring MM, Middleton D, Gardiner CM. Receptor systems controlling natural killer cell function are genetically stratified in Europe. Genes Immun 2010: 11: 67-78.
12. Single RM, Martin MP, Gao X et al. Global diversity and evidence for coevolution of KIR and HLA. Nat Genet 2007: 39: 1114-9.
13. Hiby SE, Walker JJ, O'Shaughnessy KM et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004: 200: 957-65.
14. Nelson GW, Martin MP, Gladman D, Wade J, Trowsdale J, Carrington M. Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 2004: 173: 4273-6.
15. Qi Y, Martin MP, Gao X et al. KIR/HLA pleiotropism: protection against both HIV and opportunistic infections. PLoS Pathog 2006: 2: e79.
16. Hansasuta P, Dong T, Thananchai H et al. Recognition of HLA-A3 and HLA-A11 by KIR3dl2 is peptide-specific. Eur J Immunol 2004: 34: 1673-9.
17. Stewart CA, Laugier-Anfossi F, Vely F et al. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci U S A 2005: 102: 13224-9.
18. Capittini C, Tinelli C, Guarene M et al. Possible KIR-driven genetic pressure on the genesis and maintenance of specific HLA-A, B haplotypes as functional genetic blocks. Genes Immun 2012: 13: 452-7.
19. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in 2h: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992: 39: 225-35.
20. De Vreese K, Barylski R, Pughe F et al. Performance characteristics of updated INNO-LiPA assays for molecular typing of human leukocyte antigen A (HLA-A), HLA-B, and HLA-DQB1 alleles. Clin Diagn Lab Immunol 2004: 11: 430-2.
21. Bontadini A, Testi M, Cuccia MC et al. Distribution of killer cell immunoglobulin-like receptors genes in the Italian Caucasian population. J Transl Med 2006: 4: 44.
22. Mattiuz PL, Ihde D, Piazza A, Ceppellini R, Bodmer WF. New approaches to the population genetic and segregation analysis of the HLA system. In: Terasaky PI, ed. Histocompatibility Testing. Copenhagen: Munskaard, 1970, 193-205.
23. Bauer MP, Danilovs JA. Population analysis of HLA-A, B, C, DR and other genetic markers. In: Terasaky PI, ed. Histocompatibility Testing. Los Angeles: UCLA Tissue Typing Laboratory, 1980, 955-93.
24. Lanier LL. NK cell recognition. Annu Rev Immunol 2005: 23: 225-74.
25. Rendine S, Borelli I, Barbanti M, Sacchi N, Roggero S, Curtoni ES. HLA polymorphisms in Italian bone marrow donors: a regional analysis. Tissue Antigens 1998: 52: 135-46.
26. Sivori S, Falco M, Carlomagno S et al. A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3dl2. Blood 2010: 116: 1637-47.
27. Sivori S, Falco M, Moretta L, Moretta A. Extending killer Ig-like receptor function: from HLA class I recognition to sensors of microbial products. Trends Immunol 2010: 31: 289-94.